Your application Safe freezing of CAR-T cells

The production of CAR-T cells is a highly specialised process in the field of personalised medicine. CAR T cells are patient- or donor-derived T lymphocytes that have been genetically modified so that they can recognise and specifically attack certain characteristics of cancer cells. The term "CAR" stands for "Chimeric Antigen Receptor" - an artificially inserted receptor that enables the T cells to identify and fight tumour cells independently of the body's own immune system. The freezing of CAR-T cells is more than just a logistical intermediate step - it is a critical quality point in cell therapy production. By utilising controlled, validatable freezing processes, manufacturers can ensure that each batch of cells is delivered with consistent quality and therapeutic effect. This creates the basis for scalable, safe and economical therapy solutions in the field of personalised medicine.

Safe cryopreservation for cellular immunotherapies

As CAR-T cells are living, therapeutically effective cells, they must be processed, stored and transported under strictly controlled conditions. A crucial step in the production chain is controlled freezing, also known as cryopreservation, which plays a key role in ensuring cell quality. Only a validated, reproducible freezing process can maintain the viability, functionality and therapeutic efficacy of the cells in the long term - regardless of whether they are produced directly at the treatment site or in a central manufacturing centre.

CAR T cells are extremely sensitive to physical stress, especially during the transition to the frozen state. Uncontrolled cooling can lead to the formation of ice crystals within the cell, which destroy the cell membrane and thus significantly impair the cell's ability to function. To avoid this, controlled freezing systems are used in which the cooling rate is specifically controlled. Typically, cooling takes place at around -1 degree Celsius per minute until the target temperature is reached. This precise control initiates homogeneous ice formation, which minimises structural damage and preserves the cells in a stable, storable condition.

Compliance with regulatory requirements is a key quality criterion in the GMP-compliant production of CAR-T cells. Controlled freezing systems enable defined process control with precisely adjustable temperature curves, digital recording of all parameters and seamless traceability. Modern systems are able to process different cell formats - such as cryobags or cassettes - safely and efficiently. This means that even personalised or smaller batches can be produced with consistently high quality and stored or transported safely.

Controlled freezing therefore plays a crucial role in ensuring cell integrity and product quality. It creates the basis for standardised, scalable production of CAR-T cell products and plays a key role in ensuring that the cells retain their full therapeutic efficacy until they are used on patients. A validated freezing process also offers the necessary process reliability with regard to international supply chains, warehouse logistics and clinical studies.

The application extends beyond CAR-T cells and also includes other cellular products such as tumour-infiltrating lymphocytes (TILs), natural killer cells (NK cells) or mesenchymal stem cells. In all cases, the transition to the cryogenic state can only be organised in such a way that the biological function of the cells is fully preserved if the freezing process is precisely controlled.To summarise, it can be said that cryopreservation is an essential part of the production and logistics of modern cell therapeutics. The freezing of CAR-T cells requires a high degree of process understanding, technical control and regulatory diligence. Only under these conditions can long-term storage and safe use in patients be guaranteed - a key component for the success of cellular immunotherapy.

Matching products

HOF-FTU Blood plasma freezer

Compact blood plasma freezer with integrated refrigeration technology - fast, uniform freezing with a minimal footprint and high process reliability.

PharmaBlastFreeze

Blast freezer for GMP rapid freezing processes - high freezing capacity in a small space, reproducible results and energy-efficient operation.

All Products

Our services

Processes

Energy recovery

Cold supply chain

Planning

Consultancy & Training

Product development

Special plant construction

Refrigerant information

HFO Refrigerant Report

F-gas regulation in the pharmaceutical industry

Energy Efficiency Act (EnEfG)

Energy comparison - ULT Report

Promotion of cold air cooling technology

Values - We stand for sustainable industrial refrigeration technology

Team

Vacancies

Press

Blog Refolution